
Jul 2021
Karyn’s Story
I enjoy getting the Glaucoma Newsletter in the mail, and I regularly give a donation, as it is helping myself and others with glaucoma...

Jul 2021
New Test 15 x Better for High Risk Glaucoma Detection
A new genetic test, performed on a blood or saliva sample, has the ability to identify 15 times more people at high risk of glaucoma than an existing genetic test...

Jun 2021
Glaucoma Australia Quinlivan Grant Update
The TArgeting Metabolic INsufficiency in Glaucoma with nicotinamide (TAMING) trial is a world-first randomised-controlled clinical trial to be conducted in partnership with Glaucoma Australia and the Centre for Eye Research Australia...

Jun 2021
Fixed Dose Combination Eye Drops for Glaucoma Treatment
While it is incurable, glaucoma is eminently treatable. Its progressive damage to the vision can be slowed to a crawl or stopped altogether by adequate treatment...

Jun 2021
Brian’s Story
My grandmother lived the last years of her life blind, and my doctor said it was probably glaucoma, as it was not known at that time...

Jun 2021
Vivian’s Story
I was diagnosed with glaucoma in my left eye in 1994, shortly after I had arrived in Australia from South Africa...

Jun 2021
2021 'Quinlivan’ Research Grant Applications Open
Applications for the annual Glaucoma Australia ‘Quinlivan’ Research Grants are now open

Jun 2021
A day in the life of an Orthoptist Educator – Through my eyes
As a Senior Patient Educator at Glaucoma Australia, the purpose of my role is to provide education and support to our community affected by glaucoma.

Jun 2021
Glaucoma Australia TARRGET Report 2021
The Targeting At Risk Relatives of Glaucoma patients for Early diagnosis and Treatment (TARRGET) study is a partnership project between Glaucoma Australia, ANZRAG based at Flinders University and the Lions Eye Institute.